ReviewJournal of Zhejiang University. Science. B2025

Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review.

Suya Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.